5 episodes
Breakthroughs Pfizer
-
- Science
-
-
3.7 • 30 Ratings
-
Healthcare in the modern world is changing rapidly. To help make sense of today’s challenges and tomorrow’s innovations, Pfizer UK leaders invite a variety of experts from across the pharmaceutical industry, life sciences and patient community to discuss the most pressing healthcare topics. Brought to you by Pfizer Ltd.
PP-UNP-GBR-1510 / August 2022
-
Understanding the impact of migraine
Dr Ellie Cannon is joined by Rob Music, CEO of The Migraine Trust and Gillian Ellsbury, Primary Care Medical Director at Pfizer UK, to explore the impact that migraine has on individuals and wider society.
PP-UNP-GBR-8670 / April 2024 -
Innovation in cancer: Defining the future of care
Dr Ellie Cannon is joined by Jane Lyons, CEO of Cancer52 and Stefano Podesta, Oncology Lead at Pfizer UK, to discuss the big challenges and opportunities in the fight against cancer within the UK.
PP-UNP-GBR-7436 / November 2023 -
Delivering a step forward for rare disease patients
Dr Ellie Cannon is joined by Dr. Jacqueline Barry, Chief Clinical Officer at the Cell and Gene Therapy Catapult and Owen Marks, Rare Disease Lead at Pfizer UK, to discuss the urgent need to evolve the way rare disease medicines are brought to patients, and why healthcare systems need to keep pace with scientific advancements.
PP-UNP-GBR-6142 / August 2023 -
Meeting the challenge of Antimicrobial Resistance (AMR)
Dr Ellie Cannon is joined by economist Lord Jim O’Neill (who in 2014 was commissioned to chair a review into the rising increase in drug-resistant infections) and Toby Cousens, Hospital and Internal Medicines Lead at Pfizer UK, to discuss the threat of antimicrobial resistance (AMR) and the challenges it poses both to science and wider society.
PP-UNP-GBR-4716 / May 2023 -
What can we learn from COVID-19 to address other healthcare challenges?
Join Dr Ellie Cannon as she talks to Susan Rienow (Country President, Pfizer UK) and Dr Richard Torbett (CEO, The Association of the British Pharmaceutical Industry) about the lessons learnt from the COVID-19 pandemic and how this could be applied to address other major healthcare challenges.
PP-UNP-GBR-2871 / December 2022